2 STRONG 5'-SPLICE SITES AND COMPETING, SUBOPTIMAL 3'-SPLICE SITES INVOLVED IN ALTERNATIVE SPLICING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA

被引:95
作者
OREILLY, MM
MCNALLY, MT
BEEMON, KL
机构
[1] JOHNS HOPKINS UNIV, DEPT BIOL, BALTIMORE, MD 21218 USA
[2] MED COLL WISCONSIN, DEPT MICROBIOL, MILWAUKEE, WI 53226 USA
关键词
D O I
10.1006/viro.1995.0010
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The human immunodeficiency virus type 1 (HIV-I) genome contains 20 exons that are alternatively spliced from 16 splice sites to generate more than 40 different mRNAs, including incompletely spliced and unspliced mRNAs. In contrast to avian retroviral RNA, which has a cis-acting element in gag that negatively regulates splicing (NRS), HIV-I RNA did not have any NRS sequences in the gag or pol genes detectable by a splicing inhibition assay. However, this assay demonstrated that the HIV-1 first 5' splice site competed with a cellular 5' splice site, suggesting that HIV-1 may have some strong splice sites. To extend this observation, we used a splice site swapping strategy to determine the efficiency of 14 HIV-I splice sites in human beta globin chimeras tested in transient transfection experiments. While the Ist HIV-1 5' splice site used in all spliced transcripts and the 4th 5' splice site used in most of the 2-kb transcripts were efficient, the other splice sites, including all the 3' splice sites; were less efficient, ranging in use from 25 to 60%. We propose that this range of splice site efficiencies contributes to the regulation of alternative splicing of HIV-1 mRNAs. (C) 1995 Academic Press, Inc.
引用
收藏
页码:373 / 385
页数:13
相关论文
共 61 条
  • [1] PRESENCE OF NEGATIVE AND POSITIVE CIS-ACTING RNA SPLICING ELEMENTS WITHIN AND FLANKING THE FIRST TAT CODING EXON OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    AMENDT, BA
    HESSLEIN, D
    CHANG, LJ
    STOLTZFUS, CM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (06) : 3960 - 3970
  • [2] REGULATION OF ROUS-SARCOMA VIRUS-RNA SPLICING AND STABILITY
    ARRIGO, S
    BEEMON, K
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (11) : 4858 - 4867
  • [3] ARRIGO SJ, 1991, GENE DEV, V55, P8808
  • [4] A NOVEL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROTEIN, TEV, SHARES SEQUENCES WITH TAT, ENV, AND REV PROTEINS
    BENKO, DM
    SCHWARTZ, S
    PAVLAKIS, GN
    FELBER, BK
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (06) : 2505 - 2518
  • [5] MUTATIONS IN THE REGIONS OF THE ROUS-SARCOMA VIRUS 3' SPLICE SITES - IMPLICATIONS FOR REGULATION OF ALTERNATIVE SPLICING
    BERBERICH, SL
    STOLTZFUS, CM
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (05) : 2640 - 2646
  • [6] BOUCK J, 1995, MOL CELL BIOL, V15, P2663
  • [7] REGULATION BY HIV REV DEPENDS UPON RECOGNITION OF SPLICE SITES
    CHANG, DD
    SHARP, PA
    [J]. CELL, 1989, 59 (05) : 789 - 795
  • [8] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [9] THE HUMAN IMMUNODEFICIENCY VIRUS REV PROTEIN IS A NUCLEAR PHOSPHOPROTEIN
    COCHRANE, A
    KRAMER, R
    RUBEN, S
    LEVINE, J
    ROSEN, CA
    [J]. VIROLOGY, 1989, 171 (01) : 264 - 266
  • [10] IDENTIFICATION AND CHARACTERIZATION OF INTRAGENIC SEQUENCES WHICH REPRESS HUMAN-IMMUNODEFICIENCY-VIRUS STRUCTURAL GENE-EXPRESSION
    COCHRANE, AW
    JONES, KS
    BEIDAS, S
    DILLON, PJ
    SKALKA, AM
    ROSEN, CA
    [J]. JOURNAL OF VIROLOGY, 1991, 65 (10) : 5305 - 5313